Calcium (Ca²⁺) dysregulation is a fundamental pathological mechanism shared across Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders. Calcium serves as a critical second messenger controlling neuronal survival, synaptic plasticity, neurotransmitter release, and gene expression. Disruption of calcium homeostasis leads to mitochondrial dysfunction, ER stress, activation of apoptotic pathways, and ultimately neuronal death 1.
This integration page examines calcium dysregulation mechanisms across neurodegenerative diseases, the consequences of altered calcium signaling, and therapeutic strategies targeting calcium homeostasis.
Neurons maintain cytosolic calcium at ~100 nM (resting) while extracellular calcium is ~1-2 mM and ER calcium is ~0.1-0.5 mM. This gradient is maintained by:
Calcium entry channels:
- Voltage-gated calcium channels (VGCCs)
- NMDA receptors
- AMPA receptors
- Transient receptor potential (TRP) channels
- Store-operated calcium entry (SOCE)
Calcium extrusion:
- Plasma membrane calcium ATPase (PMCA)
- Sodium-calcium exchanger (NCX)
- Mitochondrial calcium uniporter (MCU)
Calcium buffering:
- Calcium-binding proteins (calbindin, parvalbumin, calretinin)
- ER calcium stores (SERCA pumps)
- Mitochondrial calcium uptake
flowchart TD
A[Calcium Entry] --> B[Voltage-Gated Ca2+ Channels]
A --> C[NMDA/AMPA Receptors]
A --> D[TRP Channels]
A --> E[Store-Operated Ca2+ Entry]
B --> F[Cytosolic Ca2+ Rise]
C --> F
D --> F
E --> F
F --> G[Mitochondrial Ca2+ Uptake]
F --> H[ER Ca2+ Uptake]
F --> I[Buffer Protein Binding]
G --> J[ATP Production]
H --> K[ER Signaling]
I --> L[Signal Termination]
J --> M[Metabolic Regulation]
K --> N[Transcription]
L --> F
F --> O[PMCA Extrusion]
F --> P[NCX Extrusion]
O --> Q[Low Cytosolic Ca2+]
P --> Q
Calcium dysregulation is an early feature in AD pathogenesis:
Amyloid-beta and calcium: Aβ forms calcium-permeable channels in the plasma membrane and disrupts calcium homeostatic mechanisms. Aβ activates NMDA receptors, leading to calcium influx 2.
Presenilin and calcium: PSEN1 and PSEN2 mutations affect ER calcium stores. PSEN1 mutations cause increased ER calcium release through IP3 and ryanodine receptors.
Tau pathology: Hyperphosphorylated tau affects calcium handling by disrupting cytoskeleton and membrane proteins.
Synaptic calcium: Enhanced calcium entry through hyperactive NMDA receptors contributes to excitotoxicity.
Key calcium dysregulation in AD:
- Elevated resting cytosolic calcium
- Reduced calcium buffering capacity
- ER calcium store depletion
- Mitochondrial calcium overload
See Protein Aggregation Comparison for detailed information.
Calcium dysregulation is central to dopaminergic neuron vulnerability:
Dopamine metabolism: Dopamine oxidation generates reactive species that damage calcium handling proteins.
Substantia nigra vulnerability: Dopaminergic neurons have unique calcium handling properties that make them vulnerable to calcium dysregulation.
α-Synuclein and calcium: Mutant α-synuclein affects ER calcium homeostasis and mitochondrial calcium handling.
Environmental toxins: MPTP, rotenone, and 6-OHDA disrupt calcium homeostasis.
Key calcium dysregulation in PD:
- Increased basal calcium in dopaminergic neurons
- Mitochondrial calcium overload
- Altered SOCE
- Reduced calcium buffering
Key genes in PD calcium:
- SNCA - α-Synuclein
- PARK9 - ATP13A2 (lysosomal calcium)
- GCH1 - GTP cyclohydrolase 1
Calcium dysregulation contributes to motor neuron degeneration:
Excitotoxicity: Excessive glutamate release and impaired uptake lead to calcium influx through NMDA and AMPA receptors.
Mutant SOD1: Directly affects calcium handling by mitochondria and ER.
TDP-43 pathology: Affects calcium channel expression and function.
Mitochondrial calcium: Motor neurons are particularly sensitive to mitochondrial calcium overload.
Key calcium dysregulation in ALS:
- Elevated resting calcium
- Impaired calcium extrusion
- ER calcium depletion
- Mitochondrial calcium dysregulation
See TDP-43 Proteinopathy for detailed information.
Key genes in ALS calcium:
- SOD1 - Superoxide dismutase 1
- TARDBP - TDP-43
- FUS - Fused in sarcoma
- C9orf72 - Dipeptide repeat proteins
Mitochondria buffer calcium loads during synaptic activity. However, excessive calcium uptake leads to:
- Mitochondrial permeability transition: Pore opening releases cytochrome c
- ATP depletion: Calcium-induced mitochondrial dysfunction reduces ATP
- ROS generation: Calcium increases mitochondrial ROS production
- Apoptosis activation: Calcium triggers intrinsic apoptotic pathways
See Mitochondrial Dysfunction in Neurodegeneration for detailed information.
The ER is a major calcium store. ER calcium depletion triggers:
- ER stress: UPR activation
- Apoptotic signaling: CHOP expression
- Protein folding impairment: Calcium-dependent chaperone function
- Autophagy disruption: mTOR-independent autophagy activation
See ER Stress and Unfolded Protein Response for detailed information.
Excessive glutamate leads to pathological calcium influx:
- NMDA receptor overactivation: Pathological calcium influx
- AMPA receptor dysfunction: Calcium-permeable AMPA receptors
- Glutamate transport impairment: Reduced glutamate clearance
- Metabotropic glutamate receptor signaling: mGluR1/5 activation
Calcium and oxidative stress form a positive feedback loop:
- ROS and calcium channels: Oxidative modification of calcium channels
- Calcium-induced ROS: Mitochondrial calcium increases ROS
- NADPH oxidase activation: Calcium activates NOX
- Calcium pump oxidation: Oxidative damage to PMCA and SERCA
See Oxidative Stress in Neurodegeneration for detailed information.
L-type calcium channel blockers:
- Nimodipine: FDA-approved for subarachnoid hemorrhage
- Isradipine: In trials for PD
- Calsenilin modulators
NMDA receptor modulators:
- Memantine: FDA-approved for AD
- Ifenprodil: NR2B-selective antagonist
T-type calcium channel blockers:
- Ethosuximide: In trials
- Z944: In trials
Calbindin upregulation:
- Gene therapy approaches
- Small molecule inducers
Parvalbumin enhancement:
MCU inhibitors:
Mitochondrial calcium uniporter modulators:
- CoQ10: Supports mitochondrial function
- MitoQ: Mitochondria-targeted antioxidant
- Alpha-lipoic acid: Antioxidant with calcium-modulating properties
- SERCA activators: In development
- IP3 receptor modulators: In development
- Ryanodine receptor modulators: In development
- CALB1 - Calbindin
- PVALB - Parvalbumin
- CALM1 - Calmodulin
- ATP2A2 - SERCA2
- ATP2B1 - PMCA1
- SLC8A1 - NCX1
- MCU - Mitochondrial calcium uniporter
- GRIN1 - NMDA receptor subunit
- GRIN2A - NMDA receptor subunit
- CACNA1A - P/Q-type calcium channel
- CACNA1C - L-type calcium channel
- TRPM1 - Transient receptor potential
- Bezprozvanny & Mattson, Calcium Dysregulation in Neurodegeneration (2018)
- Paulus et al., Calcium in AD (2018)
- Surmeier et al., Calcium and PD Susceptibility (2017)
- Grosskreutz et al., Calcium in ALS (2018)
- Mattson & Magnus, Calcium and Neuronal Death (2006)
- Carafoli & Krebs, Calcium Signaling (2016)
- Zheng et al., Mitochondrial Calcium in Neurodegeneration (2019)
- Nixon, Calcium, Autophagy and Neurodegeneration (2018)